CBDC

Apotheca Biosciences (CE) Stock Price

0.03
0.00 (0.0%)
0.03
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Apotheca Biosciences Inc (CE) CBDC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.03 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.03
Bid Price Ask Price Spread News
0.03 0.03 0.00 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.03 USD

Apotheca Biosciences (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.45M 181.61M 14.34M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
5.96k $ - 0.00% - -

more financials information »

Apotheca Biosciences (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CBDC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.020.150.010.028492327,4140.0150.0%
1 Month0.0110.3050.010.024910216,2940.019172.73%
3 Months0.0150.3050.00050.017619118,5520.015100.0%
6 Months0.020.3050.00010.016348614,1910.0150.0%
1 Year0.010.3050.00010.015283917,0940.02200.0%
3 Years0.250.3050.00010.070224134,546-0.22-88.0%
5 Years0.250.3050.00010.070224134,546-0.22-88.0%

Apotheca Biosciences (CE) Description

Apotheca Biosciences, a biopharmaceutical company, through its divisions, engages in 1) the discovery, development, and commercialization of therapies for the treatment of opioid addiction, sleep disorder, PTSD. Alzheimer's and inflammatory diseases worldwide, 2) develops and manufactures medical devices for precise dosing, and 3) direct to business and consumer CBD enhanced supplements, formulations and cosmetics. The pipeline of products includes, transdermal, sublingual, digestive technologies and medical devices for precise and controlled dosing of cannabinoids. Products such as CannaDERME, a transdermal technology using nano-emulsion for fast absorption of cannabinoid compounds for the general pain market.


Your Recent History
USOTC
CBDC
Apotheca B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.